Skip to Main Content
Robert Bachoo, M.D.,  Ph.D.

Robert Bachoo, M.D., Ph.D.

Associate Professor

Endowed Title
Miller Family Professorship in Neuro-Oncology
School
Medical School
Department
Neurology | Internal Medicine
Graduate Programs
Cancer Biology
  • Biography

    Joined UT Southwestern: 2006

    Dr. Robert Bachoo is a physician-scientist in the Department of Neurology and holds joint appointments in the Department of Internal Medicine and the Simmons Comprehensive Cancer Center.

    Research: He leads the Neuro-Oncology Translational Laboratory in the Simmons Comprehensive Cancer Center, coordinating multidisciplinary basic, translational, and clinical brain tumor-related research. Dr. Bachoo’s research focuses on understanding the fundamental mechanisms that drive malignant brain tumors. A major emphasis of his work is developing accurate models of brain tumors, which include using genetically engineered mouse glioma models (GEMMs) as well as patient-derived xenograft (PDX) models from patients undergoing surgical resection of their tumor at UT Southwestern. His laboratory has generated one of the largest collections of brain tumor PDX models in the country and has pioneered the intra-operative metabolic tracer studies in brain tumor patients undergoing surgery for studying tumor metabolism. These clinically and molecularly annotated mouse models serve as critical discovery platforms to understand fundamental mechanisms that drive brain growth and identify potential therapeutic vulnerabilities. Insights gained from the models have contributed to overturning an 80-year-old dogma about how brain tumors fuel their growth as well as identified novel clinical imaging biomarkers and potential therapeutic targets. In addition to fostering multidisciplinary collaborative research at UTSW, Dr. Bachoo has developed strong inter-institutional collaborations with faculty in the Departments of Biomedical Engineering and Mechanical Engineering (UT Arlington and UT Dallas). Together, his research teams use biophysical approaches to understand how brain tumor cells migrate through the brain tissue, a characteristic which makes these tumors surgically incurable. These projects aim to develop novel strategies to safely and reversibly disrupt the blood-brain-barrier for drug delivery.

    Dr. Bachoo has authored more than 100 scientific peer-reviewed articles and is reviewer for more than 20 journals.  He has served on multiple NIH research study sections, including as a permanent member of the Cellular and Molecular Biology of Glia (CMBG), and on Special Emphasis Panels, including the Cancer Atlas.

    Background: Dr. Bachoo received his MD from the University of Toronto (Ontario, Canada) and his PhD from McGill University (Quebec, Canada). He completed his Neurology training at Tufts University, Boston, where he served as the Chief Resident in Neurology. Following his clinical training, he joined Dr. Ronald Depinho’s laboratory at Dana Farber Cancer Institute, Harvard University, Boston, as a post-doctoral research fellow, while serving as a Clinical Instructor in Neurology Brigham and Women’s Hospital, Harvard University. Dr. Bachoo joined as faculty of the Neurology Department at UT Southwestern Medical Center in 2006 and was named the Miller Family Professor in Neuro-Oncology.

  • Education
    Graduate School
    McGill University Faculty of Medicine (1989), Experimental Medicine
    Medical School
    University of Toronto (1996), Medicine
    Internship
    Brigham and Women's Hospital/The Faulkner Hospital (1997), Neurology
    Residency
    Tufts University (2000), Neurology
  • Research Interest
    • Blood Brain Barrier Disruption
    • Brain Tumor Metabolism
    • Malignant Transformation
    • Stem Cell Biology
    • Tumor Cell Migration
    • Tumor Microenvironment
  • Publications
    Glioblastoma Margin as a Diffusion Barrier Revealed by Photoactivation of Plasmonic Nanovesicles
    Xiong H, Wilson BA, Ge X, Gao X, Cai Q, Xu X, Bachoo R, Qin Z Nano Letters 2024 Feb 24 1570-1578
    Optical Modulation of the Blood–Brain Barrier for Glioblastoma Treatment
    Cai Q, Fan H, Li X, Giannotta M, Bachoo R, Qin Z Bio-protocol 2024 Jan 14
    Live Mapping of the Brain Extracellular Matrix and Remodeling in Neurological Disorders
    Ge X, Xu X, Cai Q, Xiong H, Xie C, Hong Y, Gao X, Yao Y, Bachoo R, Qin Z Small Methods 2024 Jan 8
    Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment
    Cai Q, Li X, Xiong H, Fan H, Gao X, Vemireddy V, Margolis R, Li J, Ge X, Giannotta M, Hoyt K, Maher E, Bachoo R, Qin Z Nature communications 2023 Dec 14
    Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution
    Zhang H, Yu X, Ye J, Li H, Hu J, Tan Y, Fang Y, Akbay E, Yu F, Weng C, Sankaran VG, Bachoo RM, Maher E, Minna J, Zhang A, Li B Cancer Cell 2023 Oct 41 1788-1802.e10
    ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
    Blandin AF, Giglio R, Graham MS, Garcia G, Malinowski S, Woods JK, Ramkissoon S, Ramkissoon L, Dubois F, Schoolcraft K, Tsai J, Wang D, Jones R, Vogelzang J, Pelton K, Becker S, Watkinson F, Sinai C, Cohen EF, Booker MA, Tolstorukov MY, Haemels V, Goumnerova L, Wright K, Kieran M, Fehnel K, Reardon D, Tauziede-Espariat A, Lulla R, Carcamo B, Chaleff S, Charest A, De Smet F, Ligon AH, Dubuc A, Pages M, Varlet P, Wen PY, Alexander BM, Chi S, Alexandrescu S, Kittler R, Bachoo R, Bandopadhayay P, Beroukhim R, Ligon KL Clinical Cancer Research 2023 Jul 29 2651-2667
    Mechanobiological modulation of blood-brain barrier permeability by laser stimulation of endothelial-targeted nanoparticles
    Li X, Cai Q, Wilson BA, Fan H, Dave H, Giannotta M, Bachoo R, Qin Z Nanoscale 2023 Jan 15 3387-3397
    Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas
    Ijare OB, Hambarde S, Brasil Da Costa FH, Lopez S, Sharpe MA, Helekar SA, Hangel G, Bogner W, Widhalm G, Bachoo RM, Baskin DS, Pichumani K Neuro-oncology 2022 Apr 24 556-568
    Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
    Parida PK, Marquez-Palencia M, Nair V, Kaushik AK, Kim K, Sudderth J, Quesada-Diaz E, Cajigas A, Vemireddy V, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, Huffman K, Sahoo S, Alluri P, Lewis C, Peng Y, Bachoo RM, Arteaga CL, Hanker AB, DeBerardinis RJ, Malladi S Cell Metabolism 2022 Jan 34 90-105.e7
    SI-MOIRAI: A new method to identify and quantify the metabolic fate of nucleotides
    Ikeda Y, Hirayama A, Kofuji S, Hirota Y, Kamata R, Osaka N, Fujii Y, Sasaki M, Ikeda S, Smith EP, Bachoo R, Soga T, Sasaki AT Journal of Biochemistry 2021 Dec 170 699-711
  • Books

    Featured 

    Glioblastoma. In Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease

    Maher E, Bachoo, R (2014). San Diego, Elsevier

  • Honors & Awards
    • American Society of Clinical Investigation
      Poster presentation award (2002)
    • Chief Resident
      Tufts University Neurology Program (1999-2000)
    • Medical Research Council of Canada Medical Scientist
      (1994-1996)
    • Heart and Stroke Foundation of Canada Medical Scientist
      (1992-1994)
    • McGill University
      Ph.D. with Honors (1989)
  • Professional Associations/Affiliations
    • American Academy of Neurology (2011)
    • American Association for Cancer Research (2006)
    • American Society of Neurology (2000)
    • American Society of Neuro-Oncology (2002)